Evidence map›Paper›PMID 38397966›Full record

ArticleBiomedicines2024

Transcriptome-Wide N6-Methyladenosine Alternations in Pulmonary Arteries of Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats and Novel Therapeutic Targets.

Yilu Feng, Zaixin Yu, Mi Tang, Jiang Li, Baohua Peng, Mukamengjiang Juaiti, Yiyang Tang, Benhui Liang, Mingqi Ouyang, Qingqing Liu and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Mesenchymal stem cell therapy for pulmonary hypertension: an update.Frontiers in bioengineering and biotechnology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yilu FengDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Zaixin YuDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Mi TangDepartment of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Jiang LiResearch Institute of Blood Lipid and Atherosclerosis, Central South University, Changsha 410011, China.
Baohua PengDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Mukamengjiang JuaitiDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Yiyang TangDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Benhui LiangDepartment of Cardiology, Xiangya Hospital, Central South University, Changsha 410008, China.
Mingqi OuyangResearch Institute of Blood Lipid and Atherosclerosis, Central South University, Changsha 410011, China.
Qingqing LiuDepartment of Respiratory and Critical Care, The Second Xiangya Hospital, Central South University, Changsha 410011, China.
Jie SongResearch Institute of Blood Lipid and Atherosclerosis, Central South University, Changsha 410011, China.ORCID 0000-0001-9285-6559
Central South University · CN

Funding

Jie Song 2020JJ5831Jie Song 81900052Mi Tang 2022JJ30840
6 · The paper itself

Abstract

N6-methyladenosine (m

Indexed as

centromere protein Fleucine rich pentatricopeptide repeat containingN6-methyladenosinepulmonary arterial hypertensionpulmonary artery smooth muscle cells

Identifiers

PMID38397966
PMCPMC10886831
OpenAlexW4391542379

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.